Demand generation for healthcare & life sciences
Health-tech, diagnostics, pharma services and medical platforms sell into long, multi-stakeholder buying cycles where clinical and commercial buyers evaluate differently - and where one careless message can burn a regulated brand. We've landed conversations at 17 of the 20 largest US pharma organizations.
Why generic outreach dies in a regulated market
Buying committees, everywhere
Clinical, commercial and procurement stakeholders evaluate the same offer through different lenses. A message that lands with one falls flat with the others.
Compliance-sensitive claims
In a regulated category, one wrong claim creates legal exposure. Messaging guardrails are table stakes here.
Gatekept buyers
The largest pharma and health-system buyers sit behind gatekeepers, filters and inboxes trained to delete anything that smells like a blast.
Cycles that outlast campaigns
Deals take quarters, not weeks. A demand channel here has to compound - volume spikes that fade after a month are worse than nothing.
Built for committees, compliance and long cycles
Clinical-grade targeting
Our signal layer reads the triggers that matter in this vertical - funding rounds, trial milestones, regulatory events, conference presence - so campaigns reach organizations already in motion.
Messaging per stakeholder
Workshops extract what actually won your existing customers, then we write and test angles separately for clinical and commercial audiences - with compliance guardrails enforced on every send.
Qualification that respects the science
Replies are screened against your fit criteria before they reach your team, so your clinical leads spend time with serious counterparties.
Results in this market
Alveo Technologies: from needle-in-a-haystack to a full partner pipeline →
Two and a half years of hunting co-development partners, solved in one quarter of signal-driven outreach.
Opportunities with 17 of the 20 largest pharma organizations in under 3 months →
Director, VP and C-suite conversations inside the hardest buyers in the market to reach cold.
Medzoomer: cracking the one channel that had always failed →
Blacklisted domains and pharmacy gatekeepers, turned into 3-5 qualified calls a week.
From first call to qualified pipeline
Tell us who you sell to
Who you sell to, your deal size, and where demand is stuck. Thirty minutes is enough to know whether the math works.
We do the homework
We assess the opportunity and unit economics at no cost, then workshop what wins from your existing customers before anything is sent.
Qualified conversations
The engine launches and vetted decision-makers start landing on your calendar - every outcome feeding the next campaign.
Tell us about your market
If you'd rather just talk, book directly - 30 minutes, no pitch deck. Otherwise share where your demand comes from today and where it's stuck.
Every intro call includes a free custom Growth Plan - yours to keep either way.
- //01 Response within 24 hours
- //02 Thorough upfront diligence at no cost
- //03 No contracts or NDAs required at this stage
- //04 Your details stay between us